Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXPX6I
|
||||
| Drug Name |
(R)-2-amino-4-(4-(difluoromethoxy)phenyl)-4-(3-(4-methoxybut-1-ynyl)phenyl)-1-methyl-1H-imidazol-5(4H)-one
|
||||
| Synonyms |
CHEMBL1271452
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C22H21F2N3O3
|
||||
| Canonical SMILES |
COCCC#Cc1cccc(c1)[C@]2(N=C(N)N(C)C2=O)c3ccc(OC(F)F)cc3
|
||||
| InChI |
InChI=1S/C22H21F2N3O3/c1-27-19(28)22(26-21(27)25,16-9-11-18(12-10-16)30-20(23)24)17-8-5-7-15(14-17)6-3-4-13-29-2/h5,7-12,14,20H,4,13H2,1-2H3,(H2,25,26)/t22-/m1/s1
|
||||
| InChIKey |
TZGLGDNNNMVJMI-JOCHJYFZSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Renin, renal | Target Info | [1587926] | ||
| Cathepsin D | Target Info | [1587926] | |||
| BioCyc Pathway | Thyroid hormone biosynthesis | ||||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| Pathway Interaction Database | LKB1 signaling events | ||||
| Ceramide signaling pathway | |||||
| Direct p53 effectors | |||||
| Validated nuclear estrogen receptor alpha network | |||||
| PathWhiz Pathway | Angiotensin Metabolism | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.